The Boeing Company
METHODS FOR MODELING INFECTIOUS DISEASE TEST PERFORMANCE AS A FUNCTION OF SPECIFIC, INDIVIDUAL DISEASE TIMELINES

Abstract:

Aspects of the disclosure provide solutions for modeling an efficacy of disease screening and testing strategies for an infectious disease. Examples include: identifying events for a disease timeline for the infectious disease, creating a model of test sensitivity as a function of the events, adaptively mapping the events to characteristics of the infectious disease unique to a simulated infected person, based at least on adaptively mapping, creating a unique disease timeline for the simulated infected person, and creating a numerical function specific to the unique disease timeline to model sensitivity as a function of the unique disease timeline.